What is 5-325 mg of oxycodone/acetaminophen la thuoc gi?

 

Oxycodone/Acetaminophen 5-325 Mg Versus Comparative Analgesic Efficacy for Short-term Pain Management in Adults After ED Discharge

According to the findings of this randomised, double-blind clinical trial, there are no clinically or statistically significant differences between the analgesic efficacy of oxycodone/acetaminophen 5-325 mg la thuoc gi and hydrocodone/acetaminophen (5/325) for the Patients who received either analgesic reported much less pain, as evidenced by pain scores that decreased by an average of more than 50% in both comparison groups. The difference in pain reduction between the two groups was only 0.4 NRS units (95% CI = 0.2 to 1.1 NRS units), which is statistically insignificant. The change in pain was nearly the same in both groups. This is significantly less than the usually accepted threshold of 1.3 NRS units needed to declare clinical significance.3-5 The research has sufficient power to identify both a clinical.

Despite a larger decrease in pain in the patients who received oxycodone/acetaminophen in the previous study than those who received hydrocodone/acetaminophen, which is considered minimally clinically significant, neither of our results led to a different conclusion regarding the effectiveness of the two analgesics. In a similar vein, a study comparing the effects of oxycodone/acetaminophen (5 mg/325 mg) and hydrocodone/acetaminophen (7.5 mg/500 mg) on dental pain following extraction of impacted third molars failed to find appreciable or statistically significant differences in pain intensity or pain relief over the course of a 6-hour period after a single dose of either combination analgesic.6

In our study, individuals treated with oxycodone/acetaminophen experienced nausea substantially more frequently than patients treated with hydrocodone/acetaminophen (17.1% vs. 7.1%, respectively; Table 3). Although there was no statistically significant difference, the magnitude and direction of the results are somewhat similar to those of the postoperative dental study (23% vs. 16%, respectively).6 While 29% of patients taking oxycodone/acetaminophen [5 mg/325 mg] and 35% of patients taking hydromorphone/acetaminophen [5 mg/325 mg] reported experiencing nausea in the 3 to 5 days following discharge from the ED, Marco et al.2 observed no difference in the incidence of nausea. The incidence of nausea with oxycodone/acetaminophen (5 mg/325 mg) was 12%8 and 10% with hydrocodone/acetaminophen in two further investigations with discharge analgesics that contrasted codeine/acetaminophen (30 mg/300 mg) and hydrocodone/acetaminophen (5 mg/325 mg).

In our study, patients who took oxycodone/acetaminophen 5-325 mg la thuoc gi

experienced dizziness substantially more frequently than those who got hydrocodone/acetaminophen (5 mg/325 mg; 17.0% vs. 7.2%; Table 3). The occurrences of dizziness between oxycodone/acetaminophen (5 mg/325 mg) and hydrocodone/acetaminophen (5 mg/325 mg), which they discovered to be 5% and 2%, respectively, respectively, were not different, according to Litkowski et al. For oxycodone/acetaminophen (5 mg/325 mg)8 and hydrocodone/acetaminophen (5 mg/325 mg), respectively, the incidences of dizziness were 10% and 14%, respectively.7 Despite the fact that the differences in nausea and vertigo in our study were "statistically significant," these results need to be regarded with caution due to the discrepancy in the studies' methods. However, if additional research demonstrates variations in nausea and vertigo with the

According to the most recent statistics from the National Hospital Ambulatory Medical Survey (NHAMCS), doctors prescribe hydrocodone/acetaminophen about 1.5 times more frequently than doctors prescribe oxycodone/acetaminophen.11 Before the FDA moved hydrocodone combination medications from Schedule III to Schedule II under the Controlled Substances Act, which went into effect in October 2014, these data were gathered in 2011.12 Physicians may have prescribed hydrocodone rather than oxycodone to lessen these unwanted consequences because Schedule III medications may have less addiction potential and result in reduced physical and psychological dependence compared to Schedule II drugs13. Additionally, Schedule II medications require handwritten prescriptions that cannot be phoned or faxed, but Schedule III pharmaceuticals can be prescribed by phoning a pharmacist or faxing a prescription.

Objectives

The goal was to determine whether oxycodone/acetaminophen works better for treating acute extremities pain after being discharged from the emergency department (ED) than hydrocodone/acetaminophen.

Methods

This study involved adult non-elderly ED patients with acute musculoskeletal extremity pain who were randomly assigned to receive either hydrocodone/acetaminophen (5 mg/325 mg) or oxycodone/acetaminophen (5 mg/325 mg) upon discharge. The main result, which was determined via phone contact 24 hours after ED discharge, was the between-group difference in improvement in numerical rating scale (NRS) pain scores over a 2-hour period after the most recent administration of study drug. Additional results included patient satisfaction, a proportionate decrease in pain, and a comparison of side-effect profiles.

Conclusions

In this study, the analgesic efficacy of oxycodone/acetaminophen 5-325 mg la thuoc gi

 and hydrocodone/acetaminophen (5 mg/325 mg) for the treatment of acute musculoskeletal extremities pain in adults after ED discharge were compared. Both medications significantly decreased pain scores—by around 50%.

Educational Objectives

Participants should be able to compare the effectiveness of oxycodone and acetaminophen to that of hydrocodone and acetaminophen after reading the article.

The Montefiore grant (1 UL1 TR001073-01) and the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein provided funding for this work.

Professor Disclosures:

Corey Heitz, MD, has no material financial interests to disclose, according to the CME Editor.

There are no relevant financial affiliations to disclose for authors Andrew K. Chang, MD, MS, Polly E. Bijur, PhD, Lynne Holden, MD, and E. John Gallagher, MD.

According to the editorial integrity and publication ethics standards upheld by Academic Emergency Medicine, this work underwent peer review. There are no pertinent financial ties between the peer reviewers. Academic Emergency Medicine uses a double-blind peer review method. As a result, in accordance with the generally acknowledged standards of medical journal peer review, the identities of the reviewers are not disclosed.